Enochian Biosciences Inc (NASDAQ: ENOB) was up 1.21% on Monday, and its shares were valued at $5.87. Last week when the company had announced that the U.S. FDA had given its nod for HIV’s “potential functional cure” drug, the investors rejoiced and pushed the stock. On June 14, the shares […]